Parkinson's Disease - Molecular Basis for Cognitive Impairment
The Molecular Basis for Cognitive Impairment in Parkinson's Disease (GAC 0156)
Protocol ID
06-108T
Protocol Description
The purpose of this study is to measure different types of brain function in patients with Parkinson's disease (PD).
Eligibility Criteria
Patients with Parkinson's disease (PD)
Primary Investigator(s)
- Andrew Feigin, MD